Invention Grant
US08791118B2 Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors
有权
吡吡嗪作为高选择性ras-Raf-Mek-Erk信号转导途径抑制剂
- Patent Title: Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors
- Patent Title (中): 吡吡嗪作为高选择性ras-Raf-Mek-Erk信号转导途径抑制剂
-
Application No.: US13439150Application Date: 2012-04-04
-
Publication No.: US08791118B2Publication Date: 2014-07-29
- Inventor: Matthias Gerlach , Irene Seipelt , Lars Blumenstein , Gilbert Mueller , Eckhard Guenther , Tilmann Schuster , Michael Teifel
- Applicant: Matthias Gerlach , Irene Seipelt , Lars Blumenstein , Gilbert Mueller , Eckhard Guenther , Tilmann Schuster , Michael Teifel
- Applicant Address: DE Frankfurt am Main
- Assignee: Aeterna Zentaris GmbH
- Current Assignee: Aeterna Zentaris GmbH
- Current Assignee Address: DE Frankfurt am Main
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP11161248 20110406
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; C07D487/04
Abstract:
The invention provides new pyridopyrazine compounds according to formula (I) which are highly selective as Ras-Raf-Mek-Erk signal transduction pathway inhibitors and in particular are highly selective Erk inhibitors.
Public/Granted literature
- US20120258080A1 PYRIDOPYRAZINE DERIVATIVES AND THEIR USE Public/Granted day:2012-10-11
Information query
IPC分类:
